ANADYS PHARMACEUTICALS INC 4/A
4/A · ANADYS PHARMACEUTICALS INC · Filed Jun 7, 2005
Insider Transaction Report
Form 4/AAmended
HBM BIOVENTURES AG
10% Owner
Transactions
- Sale
Common Stock
2005-06-02$8.59/sh−1,610$13,830→ 2,615,195 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.70/sh−300$2,610→ 2,603,145 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.45/sh−1,800$15,210→ 2,645,175 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.60/sh−5,310$45,666→ 2,609,885 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.76/sh−290$2,540→ 2,600,555 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.46/sh−2,909$24,610→ 2,642,266 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.62/sh−1,350$11,637→ 2,605,445 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.50/sh−1,391$11,824→ 2,637,825 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.47/sh−1,000$8,470→ 2,641,266 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.49/sh−2,000$16,980→ 2,639,216 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.52/sh−6,470$55,124→ 2,621,605 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.80/sh−2,400$21,120→ 2,597,055 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.79/sh−1,100$9,669→ 2,599,455 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.51/sh−9,750$82,973→ 2,628,075 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.55/sh−2,500$21,375→ 2,619,105 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.87/sh−428$3,796→ 2,596,627 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.68/sh−100$868→ 2,603,445 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.64/sh−1,900$16,416→ 2,603,545 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.48/sh−50$424→ 2,641,216 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.58/sh−2,300$19,734→ 2,616,805 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-02$8.61/sh−3,090$26,605→ 2,606,795 total(indirect: By HBM BioVentures (Cayman) Ltd.)
Footnotes (1)
- [F1]HBM BioVentures AG (the "Reporting Entity") is the sole shareholder of HBM BioVentures (Cayman) Ltd. ("HBM"), the entity that owns the reported securities.